Introduction
The term "sickle-cell disease" covers a number of genetically distinct conditions of variable clinical severity which have in common the presence of sickle haemoglobin in the red cell. Sickle haemoglobin, being relatively insoluble in the reduced form, is capable of distorting the red cell into characteristically sickle-shaped cells. These cells obstruct small blood vessels leading to scattered painful infarcts.
The sickle-cell trait is the carrier (or heterozygous) state which occurs in about 20% of West Africans and 10% of West Indians and American Negroes. These people are generally fit and sickling occurs only under conditions of severe hypoxia. The term sickle-cell anaemia should be reserved for the clinically severe homozygous state characterized by a chronic anaemia and recurrent infarctive episodes. Patients with sickle-cell haemoglobin C disease are often fit. They are nevertheless liable to occasional infarctive crises, which, when they occur, may prove fatal. It is not unusual for an adult to be unaware that he suffers from this disorder. Sickle-cell thalassaemia is less severe than classical sickle-cell anaemia. Patients suffer from a chronic haemolytic anaemia and may have a variable number of infarctive crises. The other forms of sickle-cell disease are rarely encountered.
Hypoxia sufficient to cause an infarctive sickling crisis may occur during infections or anaesthetic accidents, and the risks of these situations are documented (McCormick, 1961; Thompson, 1963; Konotey Ahulu, 1969) . A subject may also become hypoxic by flying or residing at high altitude, the arterial oxygen pressure at ground level and 5,000 and 10,000 ft (1,525 and 3,050 m) being about 100, 70, and 55 mm Hg respectively (Sluijter, 1969) . The degree of hypoxia experienced at high altitude in unpressurized aircraft may precipitate infarctive crises even in the benign sickle-cell trait. Hypoxia caused by a combination of violent exercise and residence at a moderately high altitude (4,000 ft; 1,220 m) has also been recently reported as capable of precipitating a fatal sickling crisis in sickle-cell trait carriers (Jones, Binder, and Donowho, 1970) . However, no sickling crises were reported among the African competitors with the sickle-cell trait competing in the Mexican Olympic Games at 7,000 ft (2,135 m) (A. E. Romero-Herrera, personal communication, 1970) .
Modem airliners are partially pressurized and the problems associated with the transport of cardiac and respiratory patients under these conditions have already been extensively reviewed (Beighton and Richards, 1968 Case 6.-A 48-year-old Jamaican woman flew from Antigua to San Juan in 1959 in a small unpressurized aircraft. After one hour she developed pain in the left side of the abdomen, aggravated by movement and deep breathing; this subsided over the course of four weeks. Since 1967 she has made many flights in commercial aircraft and often experienced a mild recurrence of this pain, sometimes relieved by breathing oxygen in flight, and usually taking a few days to subside. Haemoglobin studies showed the presence of haemoglobins S and C.
Case 7.-A 34-year-old Jamaican woman with sickle-cell thalassaemia developed nausea, vomiting, and a severe left-sided abdominal pain while on a flight in a pressurized aircraft between Bermuda and London. The pain subsided after four days. Before the flight her spleen tip had been palpable, but subsequently it could not be felt. She had previously flown twice in pressurized aircraft without trouble, and her return ffight was uneventfuL Discussion At a given altitude the tendency to sickling is related to the concentration of sickle haemoglobin within the red cell, which is lowest in the sickle-cell trait. Infarctive crises in this condition in unpressurized aircraft are well recognized. Sullivan (1950) Clinically, the greatest tendency to sickling occurs in sicklecell anaemia. After multiple splenic infarcts in childhood most cases of sickle-cell anaemia develop splenic scarring, and the small fibrosed splenic remnant is no longer sensitive to the insults of high altitude. Splenomegaly persists in about 10% of adults with sickle-cell anaemia in the West Indies (Serjeant, 1970a) but such cases are usually characterized by high levels of fetal haemoglobin (Serjeant, 1970b) Splenic infarction in sickle-cell haemoglobin C disease has been described during a flight in commercial aircraft flying at low altitude (4,000-6,090 ft; 1,220-1,830 m) or using a pressurized system (Doenges, Smith, Wise, and Breitenbucher, 1954; Coleman and Furth, 1955; Rotter, Luttgents, Peterson, Stock, and Motulsky, 1956) . It is often not appreciated that pressurization even in the most modern airline is still not complete; such aircraft have a "maximum differential" pressurizing system whereby the cabin altitude is related to flight altitude. For example, the Boeing 707 has a maximum cabin differential pressure of 8-6 lb/in2 (0-6 kg/cm2), sufficient to raise the atmospheric pressure at an ambient altitude of 22,500 ft (6,860 m) (6-1 lb/in2; 0A43 kg/cm2) to that present at sea level (14-7 lb/in2; 1-03 kg/cm2). Above this the cabin altitude rises accordingly, and most "pressurized" aircraft operate with a cabin atmosphere at an equivalent of between 5,000 and 7,000 ft (1,525 and 2,135 m) when flying at their normal cruising altitude. Cases 3-6 above are examples of patients with sickle-cell haemoglobin C disease who developed splenic infarction associated with a flight in a modern pressurized commercial aircraft. Erlandson, Schulnan, and Smith (1960) commented on the deleterious effect of altitude on the clinical course of sickle-cell disease. Diggs (1965) referred specifically to the potential danger of mountain trips as a factor precipitating a sickle crisis. Sicklecell anaemia seems to be clinically severe in Central Africa and relatively benign in the West Indies. It is possible that this difference in severity may be due to improved medical care and nutrition associated with higher social status, but the role of altitude may be relevant. Much of Central Africa is at an altitude of 5,000 ft (1,525 m), equivalent to that in a pressurized aircraft, whereas most of the Jamaican population is centred in large towns at sea level-for example, Kingston. Case 4 shows the effect of transporting a case of sickle-cell haemoglobin C disease from sea level to Mexico City (7,000 ft; 2,135 m). In this case either the air journey or the stay at altitude may have precipitated the crisis, but it is of interest that the symptoms subsided on the patient's return to sea level.
RECOMMENDATIONS
The Aerospace Medical Association (1961) recommended that passengers with sickle-cell anaemia and sickle-cell haemoglobin C disease should not fly. Such advice may be sound but could be severely limitng for Negro businessmen or travellers where time is important. It is preferable therefore to establish the groups with the highest risk and inform them of the dangers before travel. In our experience the most severe form of sicklecell disease, sickle-cell anaemia, seems, perhaps due to previous "autosplenectomy," to be at only slight risk when flying in pressurized aircraft. Our observations are supported by a single experiment conducted by Henderson and Thornell (1946) . They submitted a volunteer patient with "active sickle-cell anaemia" to a simulated ffight of two hours and 11 minutes. This included 30 minutes at 15,000 ft (4,570 m) and five minutes at 16,000 ft (4,875 m). At these altitudes the arterial oxygen pressure would only be about 40 mm Hg. When oxygen was subsequently administered for 10 minutes at 16,000 ft (4,875 m) it was to make further experimental observations and apparently not at the request of the patient. Though an increased number of circulating sickled cells were observed during the "flight" they reported that the patient withstood the lowered oxygen tension better than both individuals with the sickle-cell trait and normal control subjects.
Findlay, Boulter, and MacGibbon (1947) Patients with sickle-cell haemoglobin C disease seem to be at greatest risk and they should if possible completely avoid air travel. While continuous oxygen therapy could be made available in exceptional circumstances, it is not feasible as a normal commercial practice.
However, cases may be so benign as to be unsuspected until an in-flight incident occurs. The only way to avoid this situation would be to set up a screening system available to all Negro travellers, which would detect not only the presence of sickle haemoglobin but specifically cases of undiagnosed sickle-cell haemoglobin C disease, sickle-cell thalassaemia, and the unusual clinically benign cases of sickle-cell anaemia with persistent splenomegaly. The classical case of sickle-cell anaemia will almost certainly be already diagnosed. While air travel, even in pressurized aircraft, cannot be recommended for these latter patients it would seem that the risk of infarction in flight is surprisingly small.
AIRCREW FITNESS
Finally, though the foregoing reports relate to problems for airline passengers the question of sickle-cell disease and aircrew fitness needs careful consideration. Clearly, patients with the more severe sickle-cell disorders, including sickle-cell haemoglobin C disease, should not be allowed to fly as aircrew, and this attitude seems to be generally accepted. There is currently less agreement on the suitability for aircrew duties of sickle-cell trait carriers. Lewis (1970) suggested that such patients should not enter a career involving airline flying, but that those aircrew already trained who are subsequently found to have the sicklecell trait should be allowed to continue flying under medical supervision.
There seems to be little logic in this argument, which presumably advocates rejection of new entrants with the sickle-cell trait on the grounds that they may represent a safety risk. To retain those already trained, though superficially humane, seems to ignore this implied risk, and it is difficult to reconcile the two attitudes. It would seem most important that some firm, lasting, and internationally acceptable policy be defined on this subject by the authorities responsible for aircrew licensing.
We are grateful to Dr. G. Blanshard, Dr. R. P. Britt, and Wing Commander F. E. S. Keiller for permission to report cases under their care.
Introduction
It is generally agreed that the diagnosis of carcinoma of the prostate should be confirmed microscopically before treatment is started. Though an extensive transurethral prostatectomy will nearly always confirm the diagnosis (Denton et al., 1967) , there is good evidence that a specimen taken for biopsy by needle is more reliable than a limnited specimen obtained via the urethra (Purser et al., 1967) . Estimates of the accuracy of needle biopsy, however, have ranged from 50 to 90% (Kaufman et al., 1954) up to 95% (Rinker and Shuman, 1952; Bianchi, 1956) .
While the perineal route has usually been used for taking tissue from the prostate by needle, Astraldi (1937) first described good results with the transrectal approach, and noted minimal morbidity in a series of more than 100 cases. The safety and efficiency of this approach has since been confirmed by Grabstald and Elliott (1953) , Grabstald (1954 Grabstald ( , 1956 , Graham (1958) , and Daves et al. (1961) .
